Formulation and evaluation of in vitro release kinetics of na3cadtpa decorporation agent embedded in microemulsion-based gel formulation for topical delivery

Farmacia

Volumn 63, Issue 5, 2015, Pages 656-664

  Cojocaru, Victor ^a   Ranetti, Aurelian Emil ^b   Hinescu, Lavinia Georgeta ^c   Ionescu, Mihaela ^c   Cosmescu, Cristiana ^c   Poștoarcă, Angela Gabriela ^c   Cinteză, Ludmila Otilia ^d  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Central Military Hospital Bucharest   (Romania)

^c Radiobiology Department   (Romania)

^d UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Decorporation agents; Microemulsion gel; Release kinetics

Indexed keywords

CARBOPOL 934; DECORPORATION AGENT; PENTETIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ABSORPTION LAG TIME; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG RELEASE; HYDROGEL; MICROEMULSION; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOSITY;

EID: 84944735163     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Alvarez-Lorenzo C., Gomez-Amoza J.L., Martinez- Pacheco R., Souto C., Concheiro A., Microviscosity of hydroxypropylcellulose gels as a basis for prediction of drug diffusion rates. Int. J. Pharm., 1999; 180: 91-103
2. Akaike H., IEE Trans Autom Control AC, 1974; 19: 716-723
3. Aucoin H.R., Wilson A.N., Wilson A.M., Ishihara K., Guiseppi-Elie A., Release of Potassium Ion and Calcium Ion from Phosphorylcholine Group Bearing Hydrogels. Polymers, 2013; 5: 1241-1257
4. Bagwe R.P., Kanicky J.R., Palla B.J., Patanjali P.K., Shah D.O., Improved Drug Delivery Using Microemulsions: Rationale, Recent Progress, and New Horizons. Crit. Rev. Ther. Drug Carrier Syst., 2001; 18: 77-140
5. Cassatt D.R., Kaminski J.M., Hatchett R.J., DiCarlo A.L., Benjamin J.M., Maidment B.W., Medical countermeasures against nuclear threats: radionuclide decorporation agents. Radiat. Res., 2008; 170: 540-548
6. Cojocaru V., Ailiesei I., Orbeșteanu A.M., Cinteză O.L., Formulation and characterization of biocompatible microemulsions for topical administration of sodium diclofenac. Studia Universitatis ”Vasile Goldiș”, Seria Științele Vieții, 2014; 24(1): 67-71
7. Costa P., Sousa Lobo J.M., Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 2001; 13: 123-133
8. Danielsson I., Lindman B., The definition of a microemulsion. Colloids Surf. B. Biointerfaces, 1981; 3: 391-392
9. Fialho S.L., da Silva-Cunha A., New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin. Expt. Opthal., 2004; 32: 626-632
10. Friberg S.E., Micelles, microemulsions, liquid crystals, and the structure of stratum corneum lipids. J. Soc. Cosmet. Chem., 1990; 41: 155-171
11. Gupta B., Chaurasia U., Chakraborty P., Design and Development of Oral Transmucosal Film for Delivery of Salbutamol Sulphate. J. Pharm. Chem. Biol. Sci., 2014; 2(2): 118-129
12. Häntzschel D., Enders S., Kahl H., Quitzsch K., Phase behavior of quaternary systems containing carbohydrate surfactants-water-oil-cosurfactant. Phys. Chem. Chem. Phys., 1999; 1: 5703-5710
13. Hathout R.M., Mansour S., Mortada N.D., Geneidi A.S., Guy R.H., Uptake of Microemulsion Components into the Stratum Corneum and Their Molecular Effects on Skin Barrier Function. Mol. Pharmaceutics, 2010; 7: 1266-1273
14. Kogan A., Garti N., Microemulsions as transdermal drug delivery vehicles. Adv. Colloids Interface Sci., 2006; 123-126: 369-385
15. Kreilgaard M., Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev., 2002; 54 (Suppl. 1): S77-98
16. Korsmeyer R.W., Lustig S.R., Peppas N.A., Solute and penetrant diffusion in swellable polymers. I. Mathematical modeling. J. Polym. Sci. B. Polym. Phys., 1986; 24(2): 395-408
17. Korsmeyer R.W., Von Meerwall E., Peppas N.A., Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical models. J. Polym. Sci. B. Polym. Phys., 1986; 24(2): 409-434
18. Kumar P., Mittal K.L., Handbook of Microemulsion Science and Technology, Marcel Dekker, New York 1999, 139-185
19. Kyung-Mi P., Chong-Kook K., Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int. J. Pharm., 1999; 181: 173-179
20. Lianly I.L., Nandi I., Kim K.H., Development of an ethyl laurate based microemulsion for rapid onset of intranasal delivery of diazepam. Int. J. Pharm., 2002; 237: 77-85
21. Ciurba A., Todoran N., Tăurean A., Antonoaea P., Hancu G., Moisei A., Sipos E. Kinetic analysis of in vitro drug release from valproic acid and sodium valproate suppositories. Farmacia, 2014; 62 (6): 1143–1156
22. Olteanu M., Cinteză O., Dudău M., Mircioiu C., Research on the embedding of decorporators in microemulsions, in: Sohns, T.E., Voicu, V.A. (Eds.), NBC Risks. Kluwer Academic Publishers, Dordrecht, 1999, 389-400
23. Phan G., Herbet A., Cholet S., Benech H., Deverre J.R., Fattal E., Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation. J. Control. Release, 2005; 110: 177-188
24. Podlogar F., Gašperlin M., Tomšič M., Jamnik A., Bešter Rogač M., Structural characterization of water-Tween 40/Imwitor 308-isopropyl myristate microemulsions using different experimental methods. Int. J. Pharm., 2004; 276: 115-128
25. Vlaia L., Olariu I., Coneac G., Vlaia V., Popoiu C., Stănciulescu C., Muţ A.M., Szabadai Z., Lupuleasa D., Percutaneous penetration enhancement of propranolol hydrochloride from HPMC-based hydroethanolic gels containing terpenes. Farmacia, 2014; 62(5): 991-1008
26. Prieto C., Calvo L., Performance of the Biocompatible Surfactant Tween 80, for the Formation of Microemulsions Suitable for New Pharmaceutical Processing. J. Appl. Chem., 2013, 1-10
27. Ranade S., Londhe V., Bajaj A., Microemulsion based gels for targeting neuropathic pain. IJPSR, 2014; 5(6): 2525-2534
28. Reddy J.D., Cobb R.R., Dungan N.W., Matthews L.L., Aiello K.V., Ritter G., Eppler B., Kirk J.F., Abernethy J.A., Tomisaka D.M., Talton J.D., Preclinical toxicology, pharmacology, and efficacy of a novel orally administered diethylenetriaminepentaacetic acid (DTPA) formulation. Drug Dev. Res., Special Issue: Radiation, 2012; 73(5): 232-242
29. Rolland A., Demichelis G., Jamoulle J.C., Shroot B., Influence of Formulation, Receptor Fluid, and Occlusion, on in Vitro Drug Release from Topical Dosage Forms, Using an Automated Flow-through Diffusion Cell. Pharmaceut. Res., 1992; 9(1): 82-86
30. Sahoo S., Chakraborti C.K., Behera P.K., Development and Evaluation of Gastroretentive Controlled Release Polymeric Suspensions Containing Ciprofloxacin and Carbopol Polymers. J. Chem. Pharm. Res., 2012; 4: 2268-2284
31. Siepmann J., Peppas N.A., Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev., 2001; 48: 139-157
32. Southwell D., Barry B.W., Woodford R., Variations in Permeability of Human Skin within and between Specimens. Int. J. Pharm., 1984; 18(3): 299-309
33. Stemmler K., Glod G., von Gunten U., Oxidation of Metal-diethylenetriamine-Pentaacetate (DTPA)- complexes during Drinking Water Ozonation. Water Res., 2001; 35(8): 1877-1886
34. Talegaonkar S., Azeem A., Ahmad F.J., Khar R.K., Pathan S.A., Khan Z.I., Microemulsions: A Novel Approach to Enhanced Drug Delivery. Recent Pat. Drug Deliv. Formul., 2008; 2: 238-257
35. Yuan Y., Li S.M., Mo F.K., Zhong D.F., Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm., 2006; 321: 117-123
36. Zhang Y., Sadgrove M.P., Mumper R.J., Jay M., Transdermal prodrug delivery for radionuclide decorporation: non-aqueous gel formulation development and in-vitro and in-vivo assessment. Drug Dev. Res., 2013; 74: 322-331
37. Zhang Y., Sadgrove M.P., Mumper R.J., Jay M., American Medical Association: ”Radiation Emergencies”, 2005
38. Zhang Y., Sadgrove M.P., Mumper R.J., Jay M., CDC, C.f.D.C.: Frequently asked questions (FAQs) about dirty bombs, 2005
39. Zhang Y., Sadgrove M.P., Mumper R.J., Jay M. European Pharmacopoeia, 6th edition, Council of Europe, Strasbourg, 2008
40. Zhang Y., Sadgrove M.P., Mumper R.J., Jay M., Marcus C.S., California Disaster Medical Assistance Team-9, Administration of decorporation drugs to treat internal radionuclide contamination. Medical emergency response to radiologic incidents, 2004
41. Zhang Y., Sadgrove M.P., Mumper R.J., Jay M., Yaes R., Center for Drug Evaluation and Research, Medical officer review. Ca-DTPA and Zn-DTPA, 2004